Pegylated Interferon Alfa 2a
VX07-950-108
Phase 3 mab completed
Quick answer
Pegylated Interferon Alfa 2a for Hepatitis C is a Phase 3 program (mab) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Hepatitis C
- Phase
- Phase 3
- Modality
- mab
- Status
- completed